Is Halozyme Therapeutics, Inc. technically bullish or bearish?
2025-11-05 11:22:04As of 31 October 2025, the technical trend for Halozyme Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD indicates a mildly bearish stance, while the monthly MACD remains bullish. The daily moving averages are mildly bullish, and Bollinger Bands show bullish signals for both weekly and monthly time frames. However, the KST and Dow Theory indicate no clear trend on both weekly and monthly levels. In terms of performance, the stock has outperformed the S&P 500 over the past week with a return of 3.34% compared to 0.71%, but it has underperformed over the past month with a return of -1.35% against the S&P 500's 1.92%. Year-to-date, the stock has a strong return of 42.33% versus the S&P 500's 16.30%. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and Bollinger Bands....
Read full news articleIs Halozyme Therapeutics, Inc. technically bullish or bearish?
2025-11-04 11:33:28As of 31 October 2025, the technical trend for Halozyme Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is bullish, indicating mixed signals. The daily moving averages are mildly bullish, supporting a positive short-term outlook. The Bollinger Bands show a sideways trend on the weekly chart and mildly bullish on the monthly chart. KST and Dow Theory are both bullish on both weekly and monthly time frames, which adds to the overall positive sentiment. However, the weekly OBV is mildly bearish, suggesting some selling pressure. Overall, the current stance is mildly bullish, but with some caution due to mixed indicators. Multi-period return data is not available for comparison with the S&P 500....
Read full news articleIs Halozyme Therapeutics, Inc. technically bullish or bearish?
2025-11-03 11:33:14As of 31 October 2025, the technical trend for Halozyme Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD remains bullish. The daily moving averages indicate a mildly bullish stance. The KST and Dow Theory are both bullish on a weekly and monthly basis, suggesting underlying strength. However, the weekly OBV is mildly bearish, which could indicate some selling pressure. In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -1.45% and -13.01% compared to the S&P 500's gains of 0.71% and 1.92%, respectively. However, year-to-date and one-year returns are strong at 36.35% and 28.91%, respectively, outperforming the S&P 500's 16.30% and 19.89%. Overall, the current stance is mildly bullish, with mixed signals across different indicators....
Read full news articleIs Halozyme Therapeutics, Inc. technically bullish or bearish?
2025-11-02 11:17:57As of 31 October 2025, the technical trend for Halozyme Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is bullish, indicating mixed momentum. The daily moving averages are mildly bullish, suggesting some short-term strength. The Bollinger Bands show a sideways trend on the weekly chart but are mildly bullish on the monthly chart. KST and Dow Theory are both bullish across weekly and monthly time frames, reinforcing a generally positive outlook. However, the weekly OBV is mildly bearish, which could indicate some selling pressure. Overall, the technical stance is mildly bullish, with key indicators such as the monthly MACD and KST supporting this view. Unfortunately, multi-period return data is not available for comparison with the S&P 500....
Read full news article





